You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leflunomide

Showing 1 - 25 of 172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)

Recruiting
  • Idiopathic Pulmonary Hemosiderosis
  • Leflunomide
  • Leflunomide
  • Steroid Drug
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023

Henoch-Schonlein Purpura Trial in Guangzhou (Leflunomide)

Recruiting
  • Henoch-Schonlein Purpura
  • Leflunomide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 1, 2023

MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)

Not yet recruiting
  • MEN1 Gene Mutation
  • Leflunomide 20 mg
  • Basel, Switzerland
    Unispital Basel
Nov 1, 2022

Autoimmune Diseases Trial in Beijing (Diprospan plus iguratimod, Diprospan plus leflunomide, Prednisone plus leflunomide)

Recruiting
  • Autoimmune Diseases
  • Diprospan plus iguratimod
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Mar 16, 2023

Rheumatoid Arthritis, Insufficient Response to Methotrexate or Leflunomide Trial in Strasbourg (Methotrexate + targeted therapy

Recruiting
  • Rheumatoid Arthritis
  • Insufficient Response to Methotrexate or Leflunomide
  • Methotrexate + targeted therapy administration
  • methotrexate or leflunomide + sulfasalazine + hydroxychloroquine administration
  • Strasbourg, France
    Hôpitaux Universitaires de Strasbourg
Jul 8, 2022

Autoimmune Diseases Trial in Beijing (Prednisone and Mycophenolate Mofetil, Mycophenolate Mofetil, Leflunomide)

Recruiting
  • Autoimmune Diseases
  • Prednisone and Mycophenolate Mofetil
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Mar 16, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

Recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2023

PTEN-null Advanced Solid Tumors Trial in New York (Leflunomide)

Not yet recruiting
  • PTEN-null Advanced Solid Tumors
  • Leflunomide
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 8, 2022

Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

Recruiting
  • Chronic Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • Leflunomide
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Recurrent Lymphoproliferative Disorder, Refractory Lymphoproliferative Disorder Trial in Duarte (Leflunomide)

Active, not recruiting
  • Recurrent Lymphoproliferative Disorder
  • Refractory Lymphoproliferative Disorder
  • Leflunomide
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Myasthenia Gravis Trial in GuangZhou (Azathioprine, Leflunomide)

Completed
  • Myasthenia Gravis
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital, SUN YAT-SEN UNIVERSITY
Apr 6, 2022

Takayasu Arteritis Trial in China (Leflunomide 10mg Tab, Prednisone Acetate, Placebos)

Recruiting
  • Takayasu Arteritis
  • Leflunomide 10mg Tab
  • +2 more
  • Beijing, Beijing, China
  • +6 more
Jun 25, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Laboratory Biomarker Analysis, Leflunomide,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Oct 4, 2021

Musculoskeletal Disease Other, GVHD, Chronic Trial in Navi Mumbai (Leflunomide tablet)

Recruiting
  • Musculoskeletal Disease Other
  • GVHD, Chronic
  • Leflunomide tablet
  • Navi Mumbai, Maharashtra, India
    Tata Memorial Centre, Advanced Centre for Treatment, Research an
Jun 18, 2021

Primary Sjögren's Syndrome (pSS) Trial in Le Kremlin-Bicêtre (Hydroxychloroquine 400mg/d, Leflunomide 20mg/d, Mycophenolate

Recruiting
  • Primary Sjögren's Syndrome (pSS)
  • Hydroxychloroquine 400mg/d
  • +5 more
  • Le Kremlin-Bicêtre, France
    Raphaele Seror
May 2, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Dexamethasone, Leflunomide, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Duarte, California
    City of Hope Medical Center
Jan 10, 2022

COVID-19 Trial in Chertsey (leflunomide)

Active, not recruiting
  • COVID-19
  • leflunomide
  • Chertsey, United Kingdom
    Ashford and St Peters Hospital NHS Foundation Trust
Aug 12, 2021

Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Methotrexate, Adalimumab Injection)

Recruiting
  • Arthritis, Rheumatoid
  • Jinan, Shandong, China
    Qilu Hospital
Nov 28, 2022

ANCA Associated Vasculitis, Maintenance Therapy Trial in China (Leflunomide, Azathioprine Tablets)

Recruiting
  • ANCA Associated Vasculitis
  • Maintenance Therapy
  • Leflunomide
  • Azathioprine Tablets
  • Hefei, Anhui, China
  • +3 more
Nov 26, 2021

Rheumatoid Arthritis Trial in Omaha (Leflunomide, Methotrexate-Sulfasalazine-Hydroxychloroquine,

Completed
Has Results
  • Rheumatoid Arthritis
  • Leflunomide
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jan 14, 2021

Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Pondicherry, India
    Department of Clinical Immunology , Jawaharlal Institute of Post
Jul 25, 2021

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

COVID-19 Trial in Chicago (Leflunomide)

Unknown status
  • COVID-19
  • Leflunomide
  • Chicago, Illinois
    University of Chicago
Oct 27, 2020

Psoriatic Arthritis Trial in Oxford (Methotrexate, Sulfasalazine, Leflunomide)

Completed
Has Results
  • Psoriatic Arthritis
  • Oxford, Oxfordshire, United Kingdom
    Oxford University Hospitals NHS Trust
May 7, 2021